Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine

Cancer Terms -> Drugs and Chemicals -> Pharmacologic Substance -> Biological Response Modifier -> Immunoconjugate -> Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine

Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine Definition

A vaccine consisting of the oligosaccharide antigen sialyl Lewis (CA19-9) conjugated to the nonspecific immunomodulator keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. Upon administration, sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine may induce production of IgG and IgM antibodies as well as trigger an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing the sialyl Lewis antigen. Sialyl Lewis is a blood group antigen and a tumor-associated antigen associated with epithelial cancers such as breast cancer and various digestive cancers. Sialyl Lewis serves as a ligand for the cytokine-inducible cell adhesion molecule (CAM) E-selectin, an endothelial cell-specific type I transmembrane surface protein, thus facilitating hematogenous metastasis by mediating the adhesion of circulating cancer cells to vascular endothelium.

Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine Synonyms

Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine, Lucentis

Terms in Sialyl Lewis-Keyhole Limpet Hemocyanin Conjugate Vaccine category

---

Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.